News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tigermed, a China Clinical Stage CRO, Schedules ChiNext IPO


7/31/2012 12:23:02 PM

by Richard Daverman, PhD

July 31, 2012 -- Tigermed Consulting, the clinical stage CRO headquartered in Hangzhou, will stage an IPO on the ChiNext exchange. The company will offer 13.4 million A shares, which will constitute 25% of the company expanded share base. The company plans to price the offering next week on August 6. More details,,,,


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES